» Articles » PMID: 35281794

Recent Advances and Application of Whole Genome Amplification in Molecular Diagnosis and Medicine

Overview
Journal MedComm (2020)
Specialty Health Services
Date 2022 Mar 14
PMID 35281794
Authors
Affiliations
Soon will be listed here.
Abstract

Whole genome amplification (WGA) is a technology for non-selective amplification of the whole genome sequence, first appearing in 1992. Its primary purpose is to amplify and reflect the whole genome of trace tissues and single cells without sequence bias and to provide sufficient DNA template for subsequent multigene and multilocus analysis, along with comprehensive genome research. WGA provides a method to obtain a large amount of genetic information from a small amount of DNA and provides a valuable tool for preserving limited samples in molecular biology. WGA technology is especially suitable for forensic identification and genetic disease research, along with new technologies such as next-generation sequencing (NGS). In addition, WGA is also widely used in single-cell sequencing. Due to the small amount of DNA in a single cell, it is often unable to meet the amount of samples needed for sequencing, so WGA is generally used to achieve the amplification of trace samples. This paper reviews WGA methods based on different principles, summarizes both amplification principle and amplification quality, and discusses the application prospects and challenges of WGA technology in molecular diagnosis and medicine.

Citing Articles

From Conventional Detection to Point-of-care Tests (POCT) Method for Pediatric Respiratory Infections Diagnosis: A Systematic Review.

Azizian R, Mamishi S, Jafari E, Mohammadi M, Heidari Tajabadi F, Pourakbari B Arch Iran Med. 2025; 28(2):112-123.

PMID: 40062500 PMC: 11892094. DOI: 10.34172/aim.33505.


Whole-genome amplification as a tool to improve bacterial detection by PCR in microbiological samples after endodontic treatment.

Chianca G, Fendeler C, Junior S, Pereira G, Povoa H, Antunes L Front Oral Health. 2025; 6:1520945.

PMID: 39963317 PMC: 11830671. DOI: 10.3389/froh.2025.1520945.


Combining single-cell analysis and molecular docking techniques to construct a prognostic model for colon adenocarcinoma and uncovering inhibin subunit βb as a novel therapeutic target.

Wu Q, Ye L, Wu Y, Zhao M, Lu J, Yu Y Front Immunol. 2025; 15():1524560.

PMID: 39850875 PMC: 11754261. DOI: 10.3389/fimmu.2024.1524560.


Preimplantation genetic testing for four families with severe combined immunodeficiency: Three unaffected livebirths.

Zhang L, Feng L, Shi H, Niu W, Wang Y, Bu B Orphanet J Rare Dis. 2025; 20(1):14.

PMID: 39789600 PMC: 11720562. DOI: 10.1186/s13023-024-03525-y.


Backtracking Cell Phylogenies in the Human Brain with Somatic Mosaic Variants.

Bizzotto S Methods Mol Biol. 2025; 2886:201-220.

PMID: 39745642 DOI: 10.1007/978-1-0716-4310-5_10.


References
1.
Ogilvie C . Preimplantation genetic diagnosis. Lancet. 2003; 362(9379):250. DOI: 10.1016/S0140-6736(03)13928-1. View

2.
Chen M, Zhang J, Zhao J, Chen T, Liu Z, Cheng F . Comparison of CE- and MPS-based analyses of forensic markers in a single cell after whole genome amplification. Forensic Sci Int Genet. 2019; 45:102211. DOI: 10.1016/j.fsigen.2019.102211. View

3.
Green M, Sambrook J . Long and Accurate Polymerase Chain Reaction (LA PCR). Cold Spring Harb Protoc. 2019; 2019(3). DOI: 10.1101/pdb.prot095158. View

4.
Basha I, Ho E, Yousuff C, Hamid N . Towards Multiplex Molecular Diagnosis-A Review of Microfluidic Genomics Technologies. Micromachines (Basel). 2018; 8(9). PMC: 6190060. DOI: 10.3390/mi8090266. View

5.
Xu Y, Su G, Ma D, Xiao Y, Shao Z, Jiang Y . Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence. Signal Transduct Target Ther. 2021; 6(1):312. PMC: 8377461. DOI: 10.1038/s41392-021-00729-7. View